8 research outputs found
ΠΠΈΠΏΠΎΠΌΠ΅Π»Π°Π½ΠΎΠ· ΠΡΠΎ: ΠΎΠΏΠΈΡΠ°Π½ΠΈΠ΅ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠ»ΡΡΠ°Ρ
This work is devoted to a literature review and description of a clinical case of Hypomelanosis of Ito. Considering the rare frequency of the disease, not much literature data has been accumulated to date. The description of the disease can be interesting for a number of reasons. Hypomelanosis of Ito is a congenital variant of phacomatosis affecting the skin and nervous system. The disease appears sporadic. The majority of cases are diagnosed clinically, which is due to the lack of a precisely established molecular defect and, as a result, the Β«difficultiesΒ» of molecular diagnostic. This is evidenced by the absence of standard genetic analysis. Cytogenetic and molecular genetic diagnostic methods often do not establish a Β«causalΒ» mutation. This description of the clinical case of the disease is dedicated to the child who was observed in the Department of Pediatric Neurology of Saint-Petersburg State Pediatric Medical University. The patient was diagnosed clinically in early childhood; the leading symptoms of the disease were delayed speech development and epileptic seizures. No family history of neurocutaneous disorders was noted.Given the different approaches to the genetic verification of the syndrome, some methods of cytogenetic diagnostics were performed at the department, as the most frequently prescribed study to date. According to the results of the studies, no damage was found. Given the fact that genetic verification itself does not affect the prognosis and management of patients, it was decided not to continue molecular diagnostics.ΠΠ°Π½Π½Π°Ρ ΡΠ°Π±ΠΎΡΠ° ΠΏΠΎΡΠ²ΡΡΠ΅Π½Π° Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΠ½ΠΎΠΌΡ ΠΎΠ±Π·ΠΎΡΡ ΠΈ ΠΎΠΏΠΈΡΠ°Π½ΠΈΡ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠ»ΡΡΠ°Ρ Π³ΠΈΠΏΠΎΠΌΠ΅Π»Π°Π½ΠΎΠ·Π° ΠΡΠΎ. Π£ΡΠΈΡΡΠ²Π°Ρ ΡΠ΅Π΄ΠΊΡΡ ΡΠ°ΡΡΠΎΡΡ Π²ΡΡΡΠ΅ΡΠ°Π΅ΠΌΠΎΡΡΠΈ Π±ΠΎΠ»Π΅Π·Π½ΠΈ, Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΠ½ΡΡ
Π΄Π°Π½Π½ΡΡ
Π½Π° ΡΠ΅Π³ΠΎΠ΄Π½ΡΡΠ½ΠΈΠΉ Π΄Π΅Π½Ρ Π½Π°ΠΊΠΎΠΏΠ»Π΅Π½ΠΎ Π½Π΅ ΠΌΠ½ΠΎΠ³ΠΎ. ΠΠΏΠΈΡΠ°Π½ΠΈΠ΅ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ ΠΌΠΎΠΆΠ΅Ρ Π±ΡΡΡ ΠΈΠ½ΡΠ΅ΡΠ΅ΡΠ½ΡΠΌ ΠΏΠΎ ΡΡΠ΄Ρ ΠΏΡΠΈΡΠΈΠ½. ΠΠΈΠΏΠΎΠΌΠ΅Π»Π°Π½ΠΎΠ· ΠΡΠΎ ΡΠ²Π»ΡΠ΅ΡΡΡ Π²ΡΠΎΠΆΠ΄Π΅Π½Π½ΡΠΌ Π²Π°ΡΠΈΠ°Π½ΡΠΎΠΌ ΡΠ°ΠΊΠΎΠΌΠ°ΡΠΎΠ·Π°, ΠΏΠΎΡΠ°ΠΆΠ°ΡΡΠΈΠΌ ΠΊΠΎΠΆΡ ΠΈ Π½Π΅ΡΠ²Π½ΡΡ ΡΠΈΡΡΠ΅ΠΌΡ. ΠΠ°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠ΅ Π½ΠΎΡΠΈΡ ΡΠΏΠΎΡΠ°Π΄ΠΈΡΠ΅ΡΠΊΠΈΠΉ Ρ
Π°ΡΠ°ΠΊΡΠ΅Ρ. ΠΠΈΠ°Π³Π½ΠΎΠ· Π±ΠΎΠ»ΡΡΠΈΠ½ΡΡΠ²Π° ΡΠ»ΡΡΠ°Π΅Π² Π²ΡΡΡΠ°Π²Π»ΡΠ΅ΡΡΡ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈ, ΡΡΠΎ ΡΠ²ΡΠ·Π°Π½ΠΎ Ρ ΠΎΡΡΡΡΡΡΠ²ΠΈΠ΅ΠΌ ΡΠΎΡΠ½ΠΎ ΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½Π½ΠΎΠ³ΠΎ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎΠ³ΠΎ Π΄Π΅ΡΠ΅ΠΊΡΠ° ΠΈ, ΠΊΠ°ΠΊ ΡΠ»Π΅Π΄ΡΡΠ²ΠΈΠ΅, Β«ΡΠ»ΠΎΠΆΠ½ΠΎΡΡΡΠΌΠΈΒ» Π² Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ΅. ΠΡΠΎΠΌΡ ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΡΠ΅Ρ ΠΎΡΡΡΡΡΡΠ²ΠΈΠ΅ ΡΡΠ°Π½Π΄Π°ΡΡΠ½ΠΎΠ³ΠΎ Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π°. Π¦ΠΈΡΠΎΠ³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΈ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎ-Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΌΠ΅ΡΠΎΠ΄Ρ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ Π·Π°ΡΠ°ΡΡΡΡ Π½Π΅ ΡΡΡΠ°Π½Π°Π²Π»ΠΈΠ²Π°ΡΡ Β«ΠΏΡΠΈΡΠΈΠ½Π½ΡΡΒ» ΠΌΡΡΠ°ΡΠΈΡ.ΠΠ°Π½Π½ΠΎΠ΅ ΠΎΠΏΠΈΡΠ°Π½ΠΈΠ΅ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠ»ΡΡΠ°Ρ Π±ΠΎΠ»Π΅Π·Π½ΠΈ ΠΏΠΎΡΠ²ΡΡΠ΅Π½ΠΎ ΡΠ΅Π±Π΅Π½ΠΊΡ, Π½Π°Π±Π»ΡΠ΄Π°Π²ΡΠ΅ΠΌΡΡΡ Π² ΠΎΡΠ΄Π΅Π»Π΅Π½ΠΈΠΈ Π΄Π΅ΡΡΠΊΠΎΠΉ Π½Π΅Π²ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ Π‘ΠΠ±ΠΠΠΠ£. ΠΠΈΠ°Π³Π½ΠΎΠ· ΠΏΠ°ΡΠΈΠ΅Π½ΡΡ Π±ΡΠ» ΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ Π² ΡΠ°Π½Π½Π΅ΠΌ Π΄Π΅ΡΡΠΊΠΎΠΌ Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ Π² ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²ΠΈΠΈ Ρ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΠΊΡΠΈΡΠ΅ΡΠΈΡΠΌΠΈ, Π²Π΅Π΄ΡΡΠΈΠΌΠΈ ΡΠΈΠΌΠΏΡΠΎΠΌΠ°ΠΌΠΈ Π±ΠΎΠ»Π΅Π·Π½ΠΈ Π±ΡΠ»ΠΈ Π·Π°Π΄Π΅ΡΠΆΠΊΠ° ΠΏΡΠΈΡ
ΠΎΡΠ΅ΡΠ΅Π²ΠΎΠ³ΠΎ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΈ ΡΠΏΠΈΠ»Π΅ΠΏΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΡΠΈΡΡΡΠΏΡ. Π‘Π΅ΠΌΠ΅ΠΉΠ½ΡΠΉ Π°Π½Π°ΠΌΠ½Π΅Π· ΠΏΠΎ Π½Π΅ΠΉΡΠΎΠΊΠΎΠΆΠ½ΠΎΠΉ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ Π½Π΅ ΠΎΡΡΠ³ΠΎΡΠ΅Π½. Π£ΡΠΈΡΡΠ²Π°Ρ ΡΠ°Π·Π½ΡΠ΅ ΠΏΠΎΠ΄Ρ
ΠΎΠ΄Ρ ΠΊ Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ Π²Π΅ΡΠΈΡΠΈΠΊΠ°ΡΠΈΠΈ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ°, Π½Π° ΠΎΡΠ΄Π΅Π»Π΅Π½ΠΈΠΈ Π±ΡΠ»Π° ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½Π° ΡΠΈΡΠΎΠ³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠ°Ρ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ° ΠΊΠ°ΠΊ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΡΠ°ΡΡΠΎ Π½Π°Π·Π½Π°ΡΠ°Π΅ΠΌΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π½Π° ΡΠ΅Π³ΠΎΠ΄Π½ΡΡΠ½ΠΈΠΉ Π΄Π΅Π½Ρ. ΠΠΎ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ°ΠΌ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ ΠΏΠΎΠ²ΡΠ΅ΠΆΠ΄Π΅Π½ΠΈΠΉ ΠΎΠ±Π½Π°ΡΡΠΆΠ΅Π½ΠΎ Π½Π΅ Π±ΡΠ»ΠΎ. Π£ΡΠΈΡΡΠ²Π°Ρ ΡΠΎΡ ΡΠ°ΠΊΡ, ΡΡΠΎ ΡΠ°ΠΌΠ° ΠΏΠΎ ΡΠ΅Π±Π΅ Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠ°Ρ Π²Π΅ΡΠΈΡΠΈΠΊΠ°ΡΠΈΡ Π½Π΅ Π²Π»ΠΈΡΠ΅Ρ Π½Π° ΠΏΡΠΎΠ³Π½ΠΎΠ· ΠΈ ΡΠ°ΠΊΡΠΈΠΊΡ Π²Π΅Π΄Π΅Π½ΠΈΡ Π±ΠΎΠ»ΡΠ½ΡΡ
, Π±ΡΠ»ΠΎ ΠΏΡΠΈΠ½ΡΡΠΎ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ Π½Π΅ ΠΏΡΠΎΠ΄ΠΎΠ»ΠΆΠ°ΡΡ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΡΡ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΡ. Π Π½Π°ΡΡΠΎΡΡΠ΅ΠΉ ΡΠ°Π±ΠΎΡΠ΅ ΠΎΠΏΠΈΡΠ°Π½Π° ΡΠ°ΠΊΡΠΈΠΊΠ° Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ, Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ°, Π° ΡΠ°ΠΊΠΆΠ΅ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΌΠ΅Π΄ΠΈΠΊΠΎ-Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΊΠΎΠ½ΡΡΠ»ΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΡΠ΅ΠΌΡΠΈ
ΠΠΠΠΠΠ£ΠΠ―Π ΠΠ-ΠΠΠΠΠ’ΠΠ§ΠΠ‘ΠΠΠ Β«ΠΠΠ Π’Π ΠΠ’Β» Π ΠΠΠ ΠΠΠΠΠ§ΠΠΠ ΠΠΠΠΠΠ«
Understanding genetic mechanisms and detection of biological markers of tumor growth forms an individual molecular phenotype oftransformed cells that characterizes stage of tumor, the ability to metastasize, hormonal sensitivity, chemotherapyefficiencyetc. Mutations inΒ proto- and anti-oncogenes controlling mitotic activity of cells and their ability to DNA reparation are often found in tumor cells in patients withΒ cancer. Defects of classical tumor suppressor genes (BRCA1/2, CHEK2, ATM, PALB2, NBS1, TP53, etc.) determine the hereditary predispositionΒ to breast cancer caused by genomic instability and appearance of Β«chimericΒ» genes, aneuploidies and chromosomal aberrations. Breast cancer isΒ a genetically heterogeneous disease with various molecular, biological and clinical features. Identificationof the molecular phenotype of breastΒ carcinomas is an important prognostic factor of the disease, and it helps to individualize the therapeutic approach for patients.ΠΠΎΠ½ΠΈΠΌΠ°Π½ΠΈΠ΅ Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΠΎΠ² ΠΈ Π²ΡΡΠ²Π»Π΅Π½ΠΈΠ΅ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΌΠ°ΡΠΊΠ΅ΡΠΎΠ² ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΠΎΠ³ΠΎ ΡΠΎΡΡΠ° ΡΠΎΡΠΌΠΈΡΡΡΡ ΠΈΠ½Π΄ΠΈΠ²ΠΈΠ΄ΡΠ°Π»ΡΠ½ΡΠΉΒ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΡΠΉ ΡΠ΅Π½ΠΎΡΠΈΠΏ ΡΡΠ°Π½ΡΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΠΊΠ»Π΅ΡΠΎΠΊ, ΠΊΠΎΡΠΎΡΡΠΉ Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΠ·ΡΠ΅Ρ ΡΡΠ΅ΠΏΠ΅Π½Ρ Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΡΡΠΈ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ, ΡΠΏΠΎΡΠΎΠ±Π½ΠΎΡΡΡΒ ΠΊ ΠΌΠ΅ΡΠ°ΡΡΠ°Π·ΠΈΡΠΎΠ²Π°Π½ΠΈΡ, Π³ΠΎΡΠΌΠΎΠ½Π°Π»ΡΠ½ΡΡ ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡ, ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ Ρ
ΠΈΠΌΠΈΠΎΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΈ Ρ. Π΄. Π ΠΎΠΏΡΡ
ΠΎΠ»ΡΡ
ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡΠΌΠΈ ΠΎΠ±Π½Π°ΡΡΠΆΠΈΠ²Π°ΡΡΡΡ ΠΌΡΡΠ°ΡΠΈΠΈ ΠΏΡΠΎΡΠΎ- ΠΈ Π°Π½ΡΠΈΠΎΠ½ΠΊΠΎΠ³Π΅Π½ΠΎΠ², ΠΊΠΎΠ½ΡΡΠΎΠ»ΠΈΡΡΡΡΠΈΡ
ΠΌΠΈΡΠΎΡΠΈΡΠ΅ΡΠΊΡΡ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΠΊΠ»Π΅ΡΠΎΠΊ ΠΈΒ ΠΈΡ
ΡΠΏΠΎΡΠΎΠ±Π½ΠΎΡΡΡ ΠΊ ΡΠ΅ΠΏΠ°ΡΠ°ΡΠΈΠΈ ΠΠΠ. ΠΠ΅ΡΠ΅ΠΊΡΡ ΠΊΠ»Π°ΡΡΠΈΡΠ΅ΡΠΊΠΈΡ
Π³Π΅Π½ΠΎΠ²-ΡΡΠΏΡΠ΅ΡΡΠΎΡΠΎΠ² ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΠΎΠ³ΠΎ ΡΠΎΡΡΠ° (BRCA1/2, CHEK2, ATM, PALB2,Β NBS1, TP53 ΠΈ Π΄Ρ.) Π΄Π΅ΡΠ΅ΡΠΌΠΈΠ½ΠΈΡΡΡΡ Π½Π°ΡΠ»Π΅Π΄ΡΡΠ²Π΅Π½Π½ΡΡ ΠΏΡΠ΅Π΄ΡΠ°ΡΠΏΠΎΠ»ΠΎΠΆΠ΅Π½Π½ΠΎΡΡΡ ΠΊ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΡΠ°ΠΊΠ° ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ (Π ΠΠ), ΠΎΠ±ΡΡΠ»ΠΎΠ²Π»Π΅Π½Π½ΡΡ Π½Π°ΡΡΡΠ΅Π½ΠΈΠ΅ΠΌ ΡΡΠ°Π±ΠΈΠ»ΡΠ½ΠΎΡΡΠΈ Π³Π΅Π½ΠΎΠΌΠ° ΠΈ Π²ΠΎΠ·Π½ΠΈΠΊΠ½ΠΎΠ²Π΅Π½ΠΈΠ΅ΠΌ Β«Ρ
ΠΈΠΌΠ΅ΡΠ½ΡΡ
Β» Π³Π΅Π½ΠΎΠ², Π°Π½Π΅ΡΠΏΠ»ΠΎΠΈΠ΄ΠΈΠΉ ΠΈΠ»ΠΈ Ρ
ΡΠΎΠΌΠΎΡΠΎΠΌΠ½ΡΡ
Π°Π±Π΅ΡΡΠ°ΡΠΈΠΉ.Β Π ΠΠ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»ΡΠ΅Ρ ΡΠΎΠ±ΠΎΠΉ Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈ Π³Π΅ΡΠ΅ΡΠΎΠ³Π΅Π½Π½ΠΎΠ΅ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠ΅ Ρ ΡΠ°Π·Π»ΠΈΡΠ½ΡΠΌΠΈ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎ-Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΠΈ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΡΠΌΠΈ. ΠΠ΄Π΅Π½ΡΠΈΡΠΈΠΊΠ°ΡΠΈΡ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎΠ³ΠΎ ΡΠ΅Π½ΠΎΡΠΈΠΏΠ° ΠΊΠ°ΡΡΠΈΠ½ΠΎΠΌ ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ ΡΠ²Π»ΡΠ΅ΡΡΡ Π²Π°ΠΆΠ½ΡΠΌ ΠΏΡΠΎΠ³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΈΠΌΒ ΡΠ°ΠΊΡΠΎΡΠΎΠΌ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ ΠΈ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ ΠΏΠ΅ΡΡΠΎΠ½ΠΈΡΠΈΡΠΈΡΠΎΠ²Π°ΡΡ Π»Π΅ΡΠ΅Π½ΠΈΠ΅ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΠΠΠΠΠ-ΠΠΠΠΠ’ΠΠ§ΠΠ‘ΠΠΠ ΠΠΠΠ‘Π£ΠΠ¬Π’ΠΠ ΠΠΠΠΠΠ ΠΠ Π ΠΠΠ‘ΠΠΠΠ‘Π’ΠΠΠΠΠ«Π₯ Π€ΠΠ ΠΠΠ₯ Π ΠΠΠ ΠΠΠΠΠ§ΠΠΠ ΠΠΠΠΠΠ« Π Π ΠΠΠ Π―ΠΠ§ΠΠΠΠΠ
Hereditary breast and ovarian cancer is one of the most common genetic pathology. Medical and genetic counseling of patients with hereditary breast and ovarian cancer and their families plays the important role in cancer care, as it helps to develop the set of diagnostic, preventive and therapeutic measures aimed at monitoring healthy individuals and to create personalized approaches to the treatment of patients.ΠΠ°ΡΠ»Π΅Π΄ΡΡΠ²Π΅Π½Π½ΡΠΉ ΡΠ°ΠΊ ΠΌΠΎΠ»ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ ΠΈ ΡΠΈΡΠ½ΠΈΠΊΠΎΠ² ΡΠ²Π»ΡΠ΅ΡΡΡ ΠΎΠ΄Π½ΠΎΠΉ ΠΈΠ· ΡΠ°ΠΌΡΡ
ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΡΡ
Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΉ. ΠΠ΅Π΄ΠΈΠΊΠΎ-Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΊΠΎΠ½ΡΡΠ»ΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π½Π°ΡΠ»Π΅Π΄ΡΡΠ²Π΅Π½Π½ΡΠΌΠΈ ΡΠΎΡΠΌΠ°ΠΌΠΈ ΡΠ°ΠΊΠ° ΠΈ ΡΠ»Π΅Π½ΠΎΠ² ΠΈΡ
ΡΠ΅ΠΌΠ΅ΠΉ ΡΠ²Π»ΡΠ΅ΡΡΡ Π½Π΅ΠΎΡΡΠ΅ΠΌΠ»Π΅ΠΌΠΎΠΉ ΡΠΎΡΡΠ°Π²Π»ΡΡΡΠ΅ΠΉ ΠΎΠΊΠ°Π·Π°Π½ΠΈΡ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΠΎΠΌΠΎΡΠΈ, ΡΠ°ΠΊ ΠΊΠ°ΠΊ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠ°ΡΡ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΈΡ
, ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈ Π»Π΅ΡΠ΅Π±Π½ΡΡ
ΠΌΠ΅ΡΠΎΠΏΡΠΈΡΡΠΈΠΉ, Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½Π½ΡΡ
Π½Π° Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΠ΅ Π·Π° Π·Π΄ΠΎΡΠΎΠ²ΡΠΌΠΈ ΠΈΠ½Π΄ΠΈΠ²ΠΈΠ΄ΡΡΠΌΠ°ΠΌΠΈ ΠΈ ΡΠΎΠ·Π΄Π°Π½ΠΈΠ΅ ΠΏΠ΅ΡΡΠΎΠ½ΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΠΏΠΎΠ΄Ρ
ΠΎΠ΄ΠΎΠ² ΠΊ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ²
MOLECULAR-GENETIC Β«PORTRAITΒ» OF BREAST CANCER
Understanding genetic mechanisms and detection of biological markers of tumor growth forms an individual molecular phenotype oftransformed cells that characterizes stage of tumor, the ability to metastasize, hormonal sensitivity, chemotherapyefficiencyetc. Mutations inΒ proto- and anti-oncogenes controlling mitotic activity of cells and their ability to DNA reparation are often found in tumor cells in patients withΒ cancer. Defects of classical tumor suppressor genes (BRCA1/2, CHEK2, ATM, PALB2, NBS1, TP53, etc.) determine the hereditary predispositionΒ to breast cancer caused by genomic instability and appearance of Β«chimericΒ» genes, aneuploidies and chromosomal aberrations. Breast cancer isΒ a genetically heterogeneous disease with various molecular, biological and clinical features. Identificationof the molecular phenotype of breastΒ carcinomas is an important prognostic factor of the disease, and it helps to individualize the therapeutic approach for patients
MEDICAL AND GENETIC COUNSELING OF HEREDITARY BREAST AND OVARIAN CANCER
Hereditary breast and ovarian cancer is one of the most common genetic pathology. Medical and genetic counseling of patients with hereditary breast and ovarian cancer and their families plays the important role in cancer care, as it helps to develop the set of diagnostic, preventive and therapeutic measures aimed at monitoring healthy individuals and to create personalized approaches to the treatment of patients
Development of A Method for Constructing Linguistic Standards for Multi-criteria Assessment of Honeypot Efficiency
One of the pressing areas that is developing in the field of information security is associated with the use of Honeypots (virtual decoys, online traps), and the selection of criteria for determining the most effective Honeypots and their further classification is an urgent task. The main products that implement virtual decoy technologies are presented. They are often used to study the behavior, approaches and methods that an unauthorized party uses to gain unauthorized access to information system resources. Online hooks can simulate any resource, but more often they look like real production servers and workstations. A number of fairly effective developments are known that are used to solve the problems of detecting attacks on information system resources, which are based on the apparatus of fuzzy sets. They showed the effectiveness of the appropriate mathematical apparatus, the use of which, for example, to formalize the approach to the formation of a set of reference values that will improve the process of determining the most effective Honeypots. For this purpose, many characteristics have been formed (installation and configuration process, usage and support process, data collection, logging level, simulation level, interaction level) that determine the properties of online traps. These characteristics became the basis for developing a method for the formation of standards of linguistic variables for further selection of the most effective Honeypots. The method is based on the formation of a Honeypots set, subsets of characteristics and identifier values of linguistic estimates of the Honeypot characteristics, a base and derived frequency matrix, as well as on the construction of fuzzy terms and reference fuzzy numbers with their visualization. This will allow classifying and selecting the most effective virtual baits in the future